Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction PDYN Q1 2026 Earnings WiderThanExpected Loss Raises Questions Stock Edges Higher MESO Q1 2026 Earnings EPS Miss Amid Ongoing Pipeline Progress GLMD Q4 2025 Earnings WiderThanExpected Loss as Galmed Continues Clinical Development Cricut Inc CRCT Q1 2026 Earnings EPS Surges Past Estimates by 1451 Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline